Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Swanson

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Journal of the American Society of Nephrology : JASN|October 22, 2003
Hepatitis C and renal transplantation in the era of modern immunosuppressionKevin C Abbott, Jay R Bucci, Cal S Matsumoto, et al.
Lancet (London, England)|November 30, 2002
Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapyS John Swanson, Douglas A Hale, Roslyn B Mannon, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 4, 2002
Effect of donor factors on early graft survival in adult cadaveric renal transplantationS John Swanson, Iman O Hypolite, Lawrence Y C Agodoa, et al.
Transplantation|March 29, 2011
Chemokines and their receptors in human renal allotransplantationDenise J Lo, Tim A Weaver, David E Kleiner, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletionJonathan P Pearl, Jeremy Parris, Douglas A Hale, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2020
High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injuryErik Stites, Dhiren Kumar, Oyedolamu Olaitan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Functionally significant renal allograft rejection is defined by transcriptional criteriaSteven C Hoffmann, Douglas A Hale, David E Kleiner, et al.
Transplantation|July 17, 2003
Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H)Allan D Kirk, Douglas A Hale, Roslyn B Mannon, et al.
Transplantation|October 24, 2002
Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injurySteven C Hoffmann, Robert L Kampen, Shashi Amur, et al.
Transplantation|November 27, 2002
Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantationSean P Montgomery, He Xu, Douglas K Tadaki, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of the American Society of Nephrology : JASN|October 22, 2003
Hepatitis C and renal transplantation in the era of modern immunosuppressionKevin C Abbott, Jay R Bucci, Cal S Matsumoto, et al.
Lancet (London, England)|November 30, 2002
Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapyS John Swanson, Douglas A Hale, Roslyn B Mannon, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 4, 2002
Effect of donor factors on early graft survival in adult cadaveric renal transplantationS John Swanson, Iman O Hypolite, Lawrence Y C Agodoa, et al.
Transplantation|March 29, 2011
Chemokines and their receptors in human renal allotransplantationDenise J Lo, Tim A Weaver, David E Kleiner, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletionJonathan P Pearl, Jeremy Parris, Douglas A Hale, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2020
High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injuryErik Stites, Dhiren Kumar, Oyedolamu Olaitan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Functionally significant renal allograft rejection is defined by transcriptional criteriaSteven C Hoffmann, Douglas A Hale, David E Kleiner, et al.
Transplantation|July 17, 2003
Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H)Allan D Kirk, Douglas A Hale, Roslyn B Mannon, et al.
Transplantation|October 24, 2002
Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injurySteven C Hoffmann, Robert L Kampen, Shashi Amur, et al.
Transplantation|November 27, 2002
Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantationSean P Montgomery, He Xu, Douglas K Tadaki, et al.
Pageof 7